Search

everythinglearnresearchcommunity

for

Search:↓

Survivors of Stevens-Johnson syndrome/toxic epidermal necrolysis need ongoing care for various long-term health problems.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

Alopecia areata greatly harms quality of life, causing emotional and social issues.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Certain immune system proteins are important for skin healing but can cause problems if there are too many of them.

Sunlight worsens hair loss; protect scalp.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

HIV can cause various severe or unusual skin conditions that help indicate the presence and stage of the disease.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

Activin A helps heal skin wounds and protects the brain after injury.

COVID-19 infection may cause significant hair loss, but full hair recovery is likely without special treatment.

Metformin is effective for various skin disorders but may cause skin side effects.

Black dots under trichoscopy can appear in different hair and scalp conditions, not just in alopecia areata.

First Nation individuals had higher hair cortisol levels, indicating more chronic stress.

Hair extensions can cause hair loss and scalp damage, and these problems might be more common than people realize.

Cutaneous lupus erythematosus is a chronic skin disease that can progress to systemic lupus in some cases and requires treatment to prevent recurrences and scarring.

Chemotherapy can cause hair changes similar to alopecia areata, which might lead to misdiagnosis.

Transit-amplifying cells are crucial for tissue repair and can contribute to cancer when they malfunction.

Telogen effluvium is a hair loss condition with acute cases resolving quickly and chronic cases potentially lasting longer, sometimes requiring treatment.

Photobiomodulation therapy helps manage cancer treatment side effects but needs more research for optimization.

Procyanidin B-2 is safe to use on skin as a hair growth product.

Serum granulysin levels can indicate the activity and prognosis of alopecia areata.

Some patients receiving pegylated interferon alfa injections developed skin necrosis, requiring treatment adjustments or discontinuation.

Teledermatology reduces unnecessary in-person visits and improves care.

Therapeutic intervention improved the quality of life for Japanese lupus patients with skin issues.

Alfredo Rebora suggested a new, easier way to classify hair loss in Telogen Effluvium, adding a type possibly related to autoimmune diseases.

Avoiding certain fragrances improved the man's skin condition.

The CLASI is useful but needs revision to accurately assess all cutaneous lupus erythematosus subtypes.

The authors suggest that a new type of hair loss exists, which is different from alopecia areata.